| $4 Stock With an $8 Target… | | This is not a fluke…
And in the past few days it's triggered real verified trading profits of…38% profits on GILD…100% profits on PFE…and 100% on MRK!
But it's also sparked another opportunity on a tiny $4 biotech stock…
And one former Wall Street insider has profit targets set at $8 for the stock… | | | | | Tesla, Netflix Head This Week's Star-Studded Earnings Watchlist | | We've entered the meat of earnings season, and this past week's Alpha Intel Weekly Watchlist was packed with some big, market-moving names set to report.
Netflix is a true market leader that sees a ton of action, with millions of shares traded daily. IF Netflix gaps up, that tends to be bullish, but not always...
In fact, if you look at the past three earnings dates, the stock gapped up big after the Jan. 19 report… but then sold off into February. After selling off following April's report, it consolidated for a couple of months before exploding higher after the July report, getting us around $634 per share right now.
Like I always say, it's important to not only see the numbers versus the same quarter year over year, but also see how the market reacts to the numbers.
We had another major stock on this week's watchlist that reported after the bell Tuesday, as well as a breakdown of Tesla! | | | | | 2 Strong Momentum Stocks on Sale After a Recent Sell-Off | | If you've been following along with me the past few weeks, then you know the Nasdaq 100 experienced a pullback. Even as small caps and some S&P 500 stocks trade above their 50-day moving averages, growth stocks are still in recovery mode.
But while most analysts think the best days for momentum stocks are behind us, I say they're wrong...
So because there's a momentum decline in growth stocks, there are some major bargains out there that'll outperform the broader market in the near term... | | | | | One FDA decision… Two Years in the Making… Millions On the Line! | | The last time the FDA made this call, one unsuspecting ticker nearly tripled in eight days.
Soon, trading expert Lance Ippolito will reveal the ticker poised to EXPLODE following the latest FDA decision…
| | | | "I find your videos to be very informative and I hope you continue to provide them. I think you are a wonderful teacher and I love your direct and simple explanations. You don't seem to hold back and I appreciate your candor and thoroughness."
Rich D. | | | | Relative Strength is a measure of the price trend of a stock or other financial instrument compared to another stock, instrument or industry. It is calculated by taking the price of one asset and dividing it by another.
| | | | Disclaimer: The material in this document is for informational purposes based on our proprietary research. It is not an offering, specific recommendation, or a solicitation of an offer to buy or sell any securities mentioned or discussed herein.
Any performance results discussed herein represent past performance, are not a guarantee of future performance, and are not indicative of any specific investment. Due to the timing of information presented, any investment performance reflected within this document may be adjusted after the publication and distribution of this material. There can be no assurance that the future performance of any specific investment, investment strategy, or product made reference to directly or indirectly in this communication will be profitable, be equal to any corresponding indicated historical performance levels or be suitable for your portfolio. Any investment results set forth in this document are not net of expenses and execution costs, nor do they account for other relevant trading or investment fees. Please visit wealthpress.com/terms for our full Terms and Conditions. | | | | | |
This email was sent to edwardlorilla1986.paxforex@blogger.com by WealthPress LLC | |
|
|
|
|
No comments:
Post a Comment